By New Jersey State Bar Association | December 18, 2023
The NJSBA's weekly report.
By Amanda Bronstad | December 18, 2023
The U.S. Supreme Court heard oral arguments this month in the Purdue Pharma bankruptcy about third-party releases in a case that could also impact the Boy Scouts of America's Chapter 11 plan next year.
By Avalon Zoppo | December 15, 2023
Republican members of the Senate Judiciary Committee grilled Third Circuit pick Adeel Mangi over his role on an advisory board to the Rutgers' Center for Security, Race and Rights.
By Colleen Murphy | December 14, 2023
The New Jersey Supreme Court found that "a governmental entity cannot be estopped from refusing to take an action that it was never authorized to take under the law—even if it had mistakenly agreed to that action."
By Colleen Murphy | December 14, 2023
"I think what employers would really like from the Legislature is more certainty. Not making laws that, to figure out what it means, you have to go to litigation," David A. Rapuano, a partner with Archer & Greiner, said. "To me, and to my clients, it is bad policy to create laws that cannot be figured out unless a court [is involved]."
By Colleen Murphy | December 14, 2023
"The goal of the pilot program is to make the courts more efficient and cut down on governmental waste," Sen. Vince Polistina said in a statement on the bill. "However, requiring the central municipal court to handle these cases without the corresponding revenue has become unnecessarily burdensome and costly."
By Donovan Swift | December 14, 2023
Fox Rothschild welcomes back a partner; Epstein Ostrove celebrate "Giving Tuesday"; and more moves.
By Colleen Murphy | December 13, 2023
"The Senate has several days in this lame-duck session to push through another 20 to 30 judges that have been fully vetted in a historic move to get the judiciary at a vacancy level that is manageable for the people of New Jersey," New Jersey State Bar Association President Tim McGoughran said.
By Colleen Murphy | December 13, 2023
"Merck later admitted its lawsuit had no merit because it had failed to disclose prior art to the United States Patent and Trademark Office that would have resulted in the denial of patent protection for Zetia," the complaint said. "But simply by initiating the litigation, Merck triggered a 30-month stay, which precluded the Food & Drug Administration from granting final approval of Glenmark's ANDA."
By Andrew Maloney | December 13, 2023
"Firms have a greater understanding of new working practices and have revised their approach to their space," according to the latest Citi Hildebrand client advisory.
Presented by BigVoodoo
Join the industry's top owners, investors, developers, brokers and financiers for the real estate healthcare event of the year!
This event shines a spotlight on how individuals and firms are changing the investment advisory industry where it matters most.
This conference aims to help insurers and litigators better manage complex claims and litigation.
We are seeking two attorneys with a minimum of two to three years of experience to join our prominent and thriving education law practice in...
Description: Fox Rothschild has an opening in the New York office for a Real Estate Litigation Associate with three to six years of commerci...
Downtown NY property and casualty defense law firm seeks a Litigation Associate with 3+ years' experience to become a part of our team! You ...